跳至主要内容
临床试验/NCT03922152
NCT03922152已完成不适用

Short-course Accelerated 2D-radiotherapy in Palliative Treatment of Advanced Esophageal Cancer

IRCCS Azienda Ospedaliero-Universitaria di Bologna0 个研究点目标入组 17 人开始时间: 2009年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
17
主要终点
Assessment of symptoms [odynophagia, chest-back pain, dysphagia, regurgitation]

研究概览

简要总结

The study wants to define the efficacy of a short course 2D-radiation therapy in patients with symptomatic advanced esophageal cancer.

详细描述

The study wants to define the efficacy of a short course accelerated 2D-radiation therapy delivered in twice daily fractions and 2 consecutive days for symptomatic palliation of advanced esophageal cancer.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • histologically proven advanced esophageal cancer
  • excluded from curative therapy because of disease stage and/or presence of multiple comorbidities and/or poor performance status
  • age > 18 years
  • Eastern Cooperative Oncology Group (ECOG) <3

排除标准

  • prior radiotherapy to the same region

结局指标

主要结局

Assessment of symptoms [odynophagia, chest-back pain, dysphagia, regurgitation]

时间窗: 1 year

Symptoms were graded using the IAEA scoring system. Values range from 0 (no symptom) to 4 (severe symptom).

次要结局

  • Incidence of Treatment-Emergent Adverse Events [Acute radiation toxicity](1 year)
  • Assessment of the Performance Status(1 year)
  • Assessment of the Overall Survival(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alessio Giuseppe Morganti

Professor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

相似试验